In this video, Albert Rizzo, MD, speaks with allergist and immunologist Juanita Mora, MD, pediatrician John Harrington, MD, and pulmonary and critical care physician, David Hill, MD about the role of a...
In this Consultant Case Report Insights, Juan Qiu, MD, PhD and Alice Lin, BS, BA, speak about their study, “A Healthy Male With Recalcitrant Herpes Zoster.” Dr Qiu and Alice Lin give a detailed overview of...
Lisa Jones, MA, RDN, LDN, FAND; Julie Feldman, MPH, RDN
Lisa Jones, MA, RDN, LDN, FAND; Julie Feldman, MPH, RDN
In this podcast, Lisa Jones, MA, RDN, LDN, FAND, interviews Julie Feldman, MPH, RDN, about how advances in technology are improving the accessibility and effectiveness of trauma-informed nutrition...
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
In this podcast, Eyitayo Owolabi, PhD, RN, discusses how diabetes technology is being used to support and educate patients with newly diagnosed type 2 diabetes, including addressing health care access...
In this video, James Matera, DO, speaks with nephrologist Wayne Kotzker, MD, primary care physician, Maria Ciminelli, MD, cardiologist Lance Berger, MD, and nutritionist Jamie Miller, RD, about the role of...
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
In this video, James Matera, DO, discusses an overview of primary hyperoxaluria (PH), including genetic screening, the etiology and progression to end-stage kidney disease, incidence, and diagnosis of PH...
In this video, Boris Kovatchev, PhD, describes his first-of-its-kind study, which found that adding artificial intelligence (AI) technology to an artificial pancreas improves the device's efficiency and has...
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
